Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.
复制标题
DOI:
10.1038/ng.2933
复制
发表时间:
2014-05
期刊:
影响因子:
30.8
通讯作者:
Crow YJ
中科院分区:
文献类型:
--
作者:
Rice GI;Del Toro Duany Y;Jenkinson EM;Forte GM;Anderson BH;Ariaudo G;Bader-Meunier B;Baildam EM;Battini R;Beresford MW;Casarano M;Chouchane M;Cimaz R;Collins AE;Cordeiro NJ;Dale RC;Davidson JE;De Waele L;Desguerre I;Faivre L;Fazzi E;Isidor B;Lagae L;Latchman AR;Lebon P;Li C;Livingston JH;Lourenço CM;Mancardi MM;Masurel-Paulet A;McInnes IB;Menezes MP;Mignot C;O'Sullivan J;Orcesi S;Picco PP;Riva E;Robinson RA;Rodriguez D;Salvatici E;Scott C;Szybowska M;Tolmie JL;Vanderver A;Vanhulle C;Vieira JP;Webb K;Whitney RN;Williams SG;Wolfe LA;Zuberi SM;Hur S;Crow YJ
The type I interferon system is integral to human antiviral immunity. However, inappropriate stimulation or defective negative regulation of this system can lead to inflammatory disease. We sought to determine the molecular basis of genetically uncharacterized cases of the type I interferonopathy Aicardi-Goutières syndrome, and of other patients with undefined neurological and immunological phenotypes also demonstrating an upregulated type I interferon response. We found that heterozygous mutations in the cytosolic double-stranded RNA receptor gene IFIH1 (MDA5) cause a spectrum of neuro-immunological features consistently associated with an enhanced interferon state. Cellular and biochemical assays indicate that these mutations confer a gain-of-function - so that mutant IFIH1 binds RNA more avidly, leading to increased baseline and ligand-induced interferon signaling. Our results demonstrate that aberrant sensing of nucleic acids can cause immune upregulation.
登录
查看更多内容
影响因子:
9.8
作者:
Rice, Gillian;Newman, William G.;Crow, Yanick J.
通讯作者:
Crow, Yanick J.
影响因子:
30.8
作者:
Briggs, Tracy A.;Rice, Gillian I.;Daly, Sarah;Urquhart, Jill;Gornall, Hannah;Bader-Meunier, Brigitte;Baskar, Kannan;Baskar, Shankar;Baudouin, Veronique;Beresford, Michael W.;Black, Graeme C. M.;Dearman, Rebecca J.;de Zegher, Francis;Foster, Emily S.;Frances, Camille;Hayman, Alison R.;Hilton, Emma;Job-Deslandre, Chantal;Kulkarni, Muralidhar L.;Le Merrer, Martine;Linglart, Agnes;Lovell, Simon C.;Maurer, Kathrin;Musset, Lucile;Navarro, Vincent;Picard, Capucine;Puel, Anne;Rieux-Laucat, Frederic;Roifman, Chaim M.;Scholl-Buergi, Sabine;Smith, Nigel;Szynkiewicz, Marcin;Wiedeman, Alice;Wouters, Carine;Zeef, Leo A. H.;Casanova, Jean-Laurent;Elkon, Keith B.;Janckila, Anthony;Lebon, Pierre;Crow, Yanick J.
通讯作者:
Crow, Yanick J.
影响因子:
8.6
作者:
Tojo, Kana;Sekijima, Yoshiki;Ikeda, Shu-ichi
通讯作者:
Ikeda, Shu-ichi
DOI:
10.1084/jem.20021553
发表时间:
2003-03-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bennett L;Palucka AK;Arce E;Cantrell V;Borvak J;Banchereau J;Pascual V
通讯作者:
Pascual V
影响因子:
30.8
作者:
Crow, Yanick J.;Leitch, Andrea;Jackson, Andrew P.
通讯作者:
Jackson, Andrew P.